Ginkgo Bioworks Holdings (DNA) Operating Income: 2019-2024
Historic Operating Income for Ginkgo Bioworks Holdings (DNA) over the last 6 years, with Dec 2024 value amounting to -$559.8 million.
- Ginkgo Bioworks Holdings' Operating Income fell 63.06% to -$90.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$348.1 million, marking a year-over-year increase of 45.11%. This contributed to the annual value of -$559.8 million for FY2024, which is 35.24% up from last year.
- Per Ginkgo Bioworks Holdings' latest filing, its Operating Income stood at -$559.8 million for FY2024, which was up 35.24% from -$864.4 million recorded in FY2023.
- In the past 5 years, Ginkgo Bioworks Holdings' Operating Income registered a high of -$137.0 million during FY2020, and its lowest value of -$2.2 billion during FY2022.
- In the last 3 years, Ginkgo Bioworks Holdings' Operating Income had a median value of -$864.4 million in 2023 and averaged -$1.2 billion.
- Its Operating Income has fluctuated over the past 5 years, first slumped by 1,234.38% in 2021, then skyrocketed by 60.87% in 2023.
- Over the past 5 years, Ginkgo Bioworks Holdings' Operating Income (Yearly) stood at -$137.0 million in 2020, then plummeted by 1,234.38% to -$1.8 billion in 2021, then declined by 20.81% to -$2.2 billion in 2022, then surged by 60.87% to -$864.4 million in 2023, then spiked by 35.24% to -$559.8 million in 2024.